Digital technology and healthcare delivery in insulin-treated adults with diabetes: a proposal for analysis of self-monitoring blood glucose patterns using a dedicated platform
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Purpose: A remote platform for diabetes care (Roche Diabetes® Care Platform, RDCP) has been developed that allows combined face-to-face consultations and remote patient monitoring (RPM). Methods: A dedicated flowchart is proposed as a clinical approach to help healthcare professionals in the appropriate interpretation of structured self-monitoring blood glucose data, as visualized on the RDCP during the visits, and in the optimal management of patients using the integrated RDCP-RPM tools. Results: The platform organizes patterns in different blocks: (i) hypoglycemia; (ii) hyperglycemia; (iii) blood glucose variability; (iv) treatment adherence, which identifies a possible individual pattern according to glycemic control challenges, potential causal factors, and behavioral type patterns. The flowchart proposed for use of the RDCP-RPM is self-explanatory and entails 3 steps: (1) evaluation of quality and quantity of self-monitoring blood glucose data; (2) pattern analysis; (3) personalized suggestions and therapy changes. Conclusion: The main aim of the remote treatment flowchart proposed is to support healthcare professionals in the identification of hypoglycemic and hyperglycemic patterns using the RDCP regardless of the HbA 1c value and ongoing treatment, which however, become crucial in combination with pattern analysis in the therapeutical choice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When RPM is integrated with clinical decision support systems, clinicians can rapidly identify people with suboptimal risk factor control or at increased risk of hypoglycemia and those with hypoglycemia unawareness. This enables earlier, more precise treatment adjustments and reduces healthcare utilization, including emergency department visits [40, 41].”
From Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook (2026) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s009 · Cited by 1,555 · cited 2×
“The utility of SMBG in daily life is evident in insulin-treated patients with type 1 (T1D) and type 2 diabetes (T2D) [1].”
Background7. Diabetes Technology: Standards of Care in Diabetes — 2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s007 · Cited by 301
Glycemic variability: how to measure and its clinical implication for type 2 diabetes
Umpierrez, G. E., & P. Kovatchev, B. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.09.010 · Cited by 148
Cox, D. J., Kovatchev, B. P., Julian, D. M., Gonder-Frederick, L. A., Polonsky, W. H., Schlundt, D. G., & Clarke, W. L. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.6.7989471 · Cited by 137 · cited 1×
“Common measures of glycemic variability include standard deviation (SD), low blood glucose index (LBGI), high blood glucose index (HBGI), and coef fi cient of variation (CV) [23 – 26].”
BackgroundMannucci, E., Antenore, A., Giorgino, F., & Scavini, M. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817719290 · Cited by 90 · cited 1×
“Structured SMBG follows different monitoring patterns and improves glycemic control, [5] variability, and better quality of life in insulin-treated patients [6, 7].”
BackgroundPolonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Axel-Schweitzer, M., Petersen, B., & Wagner, R. S. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0073 · Cited by 85 · cited 2×
“1S) [17].”
BackgroundPleus, S., Freckmann, G., Schauer, S., Heinemann, L., Ziegler, R., Ji, L., Mohan, V., Calliari, L. E., & Hinzmann, R. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01254-8 · Cited by 55 · cited 2×
“Structured SMBG follows different monitoring patterns and improves glycemic control, [5] variability, and better quality of life in insulin-treated patients [6, 7].”
BackgroundThe AMD ANNALS: A continuous initiative for the improvement of type 2 diabetes care
Russo, G., Di Bartolo, P., Candido, R., Lucisano, G., Manicardi, V., Giandalia, A., Nicolucci, A., Rocca, A., Rossi, M. C., & Di Cianni, G. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110672 · Cited by 39 · cited 1×
“Despite the recognized bene fi ts of SMBG, roughly 54.6% of patients treated with insulin meet their desired target for glycated hemoglobin (HbA 1c ) [3].”
BackgroundInfluentialDi Molfetta, S., Bosi, E., Ceriello, A., Cucinotta, D., Tiengo, A., Scavini, M., Piccolo, C., Bonizzoni, E., Acmet, E., & Giorgino, F. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109070 · Cited by 10
Self-citation
Research works printed but not linked: 19
- D.M. Nathan, S. Genuth, J. Lachin, P. Cleary et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med 329, 977–986 (1993). https://doi.org/10.1056/NEJM199309303291401 · DOI · Paper page
- D.T. Juarez, T. Sentell, S. Tokumaru, R. Goo, J.W. Davis, M.M. Mau, Factors associated with poor glycemic control or wide glycemic variability among diabetes patients in Hawaii, 2006-2009. Prev. Chronic Dis. 9, 120065 (2012). https://doi.org/10.5888/pcd9.120065 · DOI · Paper page
- D.M. Williams, S.N. Parsons, G.J. Dunseath, J.W. Stephens, S.D. Luzio, D.R. Owens, The impact of structured self-monitoring of blood glucose on glycaemic variability in non-insulin treated type 2 diabetes: The SMBG study, a 12-month randomised controlled trial. Diabetes Metab. Syndr. 14, 101–106 (2020). https://doi.org/10.1016/j.dsx.2020.01.006 · DOI
- B. Kulzer, W. Daenschel, I. Daenschel, E.G. Siegel, W. Schramm, C.G. Parkin et al. Integrated Personalized Diabetes Management (PDM): Design of the ProValue studies: Prospective, cluster-randomized, controlled, intervention trials for evaluation of the effectiveness and benefit of PDM in patients With Insulin-treated Type 2 Diabetes. J. Diabetes Sci. Technol. 10, 772–781 (2016). https://doi.org/10.1177/1932296815617487 · DOI
- A.R. Montero, D. Toro-Tobon, K. Gann, C.M. Nassar, G.A. Youssef, M.F. Magee, Implications of remote monitoring Technology in Optimizing Traditional Self-Monitoring of blood glucose in adults with T2DM in primary care. BMC Endocr. Disord. 21, 222 (2021). https://doi.org/10.1186/s12902-021-00884-6 · DOI
- D. Verma, Y. Bahurupi, R. Kant, M. Singh, P. Aggarwal, V. Saxena, Effect of mHealth Interventions on Glycemic Control and HbA1c Improvement among Type II Diabetes patients in Asian population: A systematic review and meta-analysis. Indian J. Endocrinol. Metab. 25, 484–492 (2021). https://doi.org/10.4103/ijem.ijem_387_21 · DOI
- J. Kang, Y. Chen, Y. Zhao, C. Zhang, Effect of remote management on comprehensive management of diabetes mellitus during the COVID-19 epidemic. Prim. Care Diabetes 15, 417–423 (2021). https://doi.org/10.1016/j.pcd.2020.12.004 · DOI
- R.S.H. Istepanian, T.M. Al-Anzi, m-Health interventions for diabetes remote monitoring and self management: clinical and compliance issues. Mhealth 4, 4 (2018). https://doi.org/10.21037/mhealth.2018.01.02 · DOI · Paper page
- G.T. Russo, F. Andreozzi, M. Calabrese, P. Di Bartolo, G. Di Cianni, C. Bruno Giorda et al. Role of telemedicine during COVID-19 pandemic in type 2 diabetes outpatients: The AMD annals initiative. Diabetes Res Clin. Pr. 194, 110158 (2022). https://doi.org/10.1016/j.diabres.2022.110158 · DOI
- IDF Diabetes Atlas, 10th Edition. Available at: https://diabetesatlas.org. Accessed 7th Jan, 2022.
- P. Choudhary, S. Genovese, G. Reach, Blood glucose pattern management in diabetes: creating order from disorder. J. Diabetes Sci. Technol. 7, 1575–1584 (2013). https://doi.org/10.1177/193229681300700618 · DOI · Paper page
- M. Grady, D. Campbell, K. MacLeod, A. Srinivasan, Evaluation of a blood glucose monitoring system with automatic high- and low-pattern recognition software in insulin-using patients: pattern detection and patient-reported insights. J. Diabetes Sci. Technol. 7, 970–978 (2013). https://doi.org/10.1177/193229681300700419 · DOI
- J.H. Cho, S.A. Chang, H.S. Kwon, Y.H. Choi, S.H. Ko, S.D. Moon et al. Long-term effect of the Internet-based glucose monitoring system on HbA1c reduction and glucose stability: a 30-month follow-up study for diabetes management with a ubiquitous medical care system. Diabetes Care 29, 2625–2631 (2006). https://doi.org/10.2337/dc05-2371 · DOI · Paper page
- J. Pearson, R. Bergenstal, Fine-tuning control: pattern management versus supplementation: view 1: pattern management: an essential component of effective insulin management. Diabetes Spectr. 14, 75–78 (2001). https://doi.org/10.2337/diaspect.14.2.75 · DOI
- B.P. Kovatchev, D.J. Cox, L.A. Gonder-Frederick, D. Young-Hyman, D. Schlundt, W. Clarke, Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care 21, 1870–1875 (1998). https://doi.org/10.2337/diacare.21.11.1870 · DOI · Paper page
- B.P. Kovatchev, M. Straume, D.J. Cox, L.S. Farhy, Risk analysis of blood glucose data: a quantitative approach to optimizing the control of insulin dependent diabetes. J. Theor. Med. 3, 1–10 (2000). https://doi.org/10.1080/10273660008833060 · DOI · Paper page
- H. Forde, P. Choudhary, P. Hammond, S. Hussain, Remote consultations for diabetes care in a post COVID-19 world. Diabet. Med 40, 14977 (2023). https://doi.org/10.1111/dme.14977 · DOI
- C. Irace, M.A. Schweitzer, C. Tripolino, F.B. Scavelli, A. Gnasso, Diabetes data management system to improve glycemic control in people with Type 1 Diabetes: Prospective Cohort Study. JMIR Mhealth Uhealth 5, 170 (2017). https://doi.org/10.2196/mhealth.8532 · DOI
- M. Parise, L. Tartaglione, A. Cutruzzolà, M.I. Maiorino, K. Esposito, D. Pitocco et al. Teleassistance for patients with Type 1 Diabetes during the COVID-19 pandemic: Results of a pilot study. J. Med Internet Res 23, 24552 (2021). https://doi.org/10.2196/24552 · DOI
Cited by
Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook
Guo, L.-J., Low, K.-S., Tae, S.-K., & Lim, L.-L. (2026) · Current Diabetes Reports · doi:10.1007/s11892-026-01633-6
Metadata
- Authors
- Irace, C., Acmet, E., Cutruzzolà, A., Parise, M., Ponzani, P., Scarpitta, A. M., & Candido, R.
- Venue
- Endocrine
- Published
- 2023-11-23
- Volume
- 84
- Issue
- 2
- Pages
- 441-449
- ISSN
- 1559-0100
- Cited by
- 6
- References
- 10
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Digital technology and healthcare delivery in insulin-treated adults with diabetes: a proposal for analysis of self-monitoring blood glucose patterns using a dedicated platform. https://app.cochat.ai/papers/10.1007/s12020-023-03605-2
- The paper
- Irace, C., Acmet, E., Cutruzzolà, A., Parise, M., Ponzani, P., Scarpitta, A. M., & Candido, R. (2023). Digital technology and healthcare delivery in insulin-treated adults with diabetes: a proposal for analysis of self-monitoring blood glucose patterns using a dedicated platform. Endocrine. https://doi.org/10.1007/s12020-023-03605-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.